ES2100452T3 - Composiciones de liposomas de fotosensibilizadores de porfirina. - Google Patents

Composiciones de liposomas de fotosensibilizadores de porfirina.

Info

Publication number
ES2100452T3
ES2100452T3 ES93300863T ES93300863T ES2100452T3 ES 2100452 T3 ES2100452 T3 ES 2100452T3 ES 93300863 T ES93300863 T ES 93300863T ES 93300863 T ES93300863 T ES 93300863T ES 2100452 T3 ES2100452 T3 ES 2100452T3
Authority
ES
Spain
Prior art keywords
photosensitizers
porphyrine
liposomes
compositions
porphyrin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93300863T
Other languages
English (en)
Inventor
Narendra Raghunathji Desai
Bushra J Agha
Kalidas Madhavrao Kale
James R Lawter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novelion Therapeutics Inc
Original Assignee
Quadra Logic Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadra Logic Technologies Inc filed Critical Quadra Logic Technologies Inc
Application granted granted Critical
Publication of ES2100452T3 publication Critical patent/ES2100452T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

SE PRESENTAN FORMULACIONES FARMACEUTICAS LIPOSOMIALES QUE INCORPORAN FOTOSENSIBILIZADORES DE PORFIRINA UTILES PARA TERAPIAS FOTODINAMICAS O PARA LA DIAGNOSIS DE CELULAS MALIGNAS. LAS FORMULACIONES LIPOSOMIALES COMPRENDEN UN FOTOSENSIBILIZADOR DE PORFIRINA, PARTICULARMENTE HIDRO-MONO-BENZOPORFIRINAS (BPD) QUE TENGAN UNA ABSORCION MAXIMA DE LA LUZ EN LA BANDA DE ENTRE 670 Y 780 NANOMETROS, UN DISACARIDO O POLISACARIDO Y UNO O MAS FOSFOLIPIDOS.
ES93300863T 1992-02-05 1993-02-05 Composiciones de liposomas de fotosensibilizadores de porfirina. Expired - Lifetime ES2100452T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83254292A 1992-02-05 1992-02-05

Publications (1)

Publication Number Publication Date
ES2100452T3 true ES2100452T3 (es) 1997-06-16

Family

ID=25261954

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93300863T Expired - Lifetime ES2100452T3 (es) 1992-02-05 1993-02-05 Composiciones de liposomas de fotosensibilizadores de porfirina.

Country Status (11)

Country Link
US (1) US6074666A (es)
EP (1) EP0569113B1 (es)
JP (1) JP3020372B2 (es)
KR (1) KR970007303B1 (es)
AT (1) ATE151984T1 (es)
CA (1) CA2087902C (es)
DE (1) DE69310014T2 (es)
DK (1) DK0569113T3 (es)
ES (1) ES2100452T3 (es)
GR (1) GR3023906T3 (es)
MX (1) MX9300560A (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890555B1 (en) * 1992-02-05 2005-05-10 Qlt, Inc. Liposome compositions of porphyrin photosensitizers
AR002009A1 (es) * 1994-12-22 1998-01-07 Astra Ab Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco.
US5707608A (en) * 1995-08-02 1998-01-13 Qlt Phototherapeutics, Inc. Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizer
JP2001511128A (ja) * 1997-01-28 2001-08-07 ファルマシア・アンド・アップジョン・カンパニー 水不溶性ポルフィリンの脂質錯体の凍結乾燥物
WO1999013916A2 (en) * 1997-09-18 1999-03-25 Nycomed Imaging As Methods and compositions for medical imaging
EP0911023A1 (en) * 1998-03-20 1999-04-28 Mario Luca Russo Pharmaceutical or cosmetic compositions containing photosensitizing substances
DE19852245A1 (de) * 1998-11-12 2000-05-18 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Nanoemulsion
CN1185008C (zh) * 1999-01-27 2005-01-19 泰立克公司 含有谷胱甘肽类似物的治疗用组合物
US6608050B2 (en) 1999-07-20 2003-08-19 Pharmacia & Upjohn Company Lyophilizate of lipid complex of water insoluble porphyrins
IL151833A0 (en) * 2000-03-24 2003-04-10 Novartis Ag Improved treatment of neovascularization
AU2001258117A1 (en) * 2000-05-08 2001-11-20 The University Of British Columbia Supports for photosensitizer formulations
US6984395B2 (en) * 2001-04-11 2006-01-10 Qlt, Inc. Drug delivery system for hydrophobic drugs
EP1465590B1 (en) * 2001-11-02 2008-03-26 The Governors Of The University Of Alberta Micelle compositions containing pegylated phospholipids and a photosensitizer
CA2513133A1 (en) 2003-01-16 2004-07-29 Techno Mart Co., Ltd. Porphyrin derivatives
US20040220167A1 (en) * 2003-05-02 2004-11-04 Nasrollah Samiy Methods of treating neuralgic pain
JP4741205B2 (ja) * 2003-07-07 2011-08-03 真 湯浅 金属ポルフィリン錯体包埋リポソーム、その製造方法およびこれを利用する医薬
US20050048109A1 (en) * 2003-08-26 2005-03-03 Ceramoptec Industries, Inc. Non-polar photosensitizer formulations for photodynamic therapy
US8986731B2 (en) 2003-08-26 2015-03-24 Biolitec Pharma Marketing Ltd Pegylated liposomal formulations of hydrophobic photosensitizers for photodynamic therapy
US8709449B2 (en) * 2004-02-12 2014-04-29 Biolitec Pharma Marketing Ltd Methods and compositions for improving photodynamic therapy through administration of lipids
US20070031482A1 (en) * 2005-08-02 2007-02-08 Ceramoptec Industries, Ind. PDT treatment method for cellulites and cosmetic use
CA2631243A1 (en) * 2005-12-08 2007-06-14 Wyeth Liposomal compositions
US7465312B2 (en) 2006-05-02 2008-12-16 Green Medical, Inc. Systems and methods for treating superficial venous malformations like spider veins
WO2007130465A2 (en) * 2006-05-02 2007-11-15 Green Medical, Inc. Systems and methods for treating superficial venous malformations like spider veins
EP2034963B1 (en) * 2006-05-18 2022-08-10 biolitec Unternehmensbeteiligungs II AG Gel-formulations of hydrophobic photosensitizers for mucosal applications
WO2008088037A1 (ja) * 2007-01-18 2008-07-24 National University Corporation Chiba University 微粒子製剤
EP2222277A4 (en) * 2007-11-15 2014-10-15 Biolitec Pharma Ip & Invest Ltd PEGYLATED LIPOSOMAL FORMULATIONS FOR PHOTODYNAMIC TREATMENT OF INFLAMMATORY DISEASES
WO2009067203A1 (en) * 2007-11-19 2009-05-28 Ceramoptec Industries, Inc. Pegylated compounds for age-related macular degeneration
US20100310660A1 (en) * 2009-06-08 2010-12-09 Taipei Medical University Dry powder microparticles for pulmonary delivery
US9211214B2 (en) 2012-03-21 2015-12-15 Valeant Pharmaceuticals International, Inc Photodynamic therapy laser
KR102630617B1 (ko) * 2016-06-24 2024-01-29 (주) 에이치엔에이파마켐 페오포르비드 a 및 폴리에틸렌글리콜의 지질 유도체의 결합체를 함유하는 항균 리포좀 조성물
WO2019173884A1 (pt) * 2018-03-15 2019-09-19 Bebeachibuli Romeo Normalizador biológico, processo de obtenção de normalizador biológico e produtos obtidos com o normalizador biológico

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
JPS60188329A (ja) * 1984-03-07 1985-09-25 Ajinomoto Co Inc リポソ−ム封入物質移入促進剤
US4880635B1 (en) * 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
US4776991A (en) * 1986-08-29 1988-10-11 The United States Of America As Represented By The Secretary Of The Navy Scaled-up production of liposome-encapsulated hemoglobin
US4920143A (en) * 1987-04-23 1990-04-24 University Of British Columbia Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
JPH0780887B2 (ja) * 1988-07-19 1995-08-30 ザ ユニバーシティ オブ ブリティッシュ コロンビア 波長特異的細胞毒性試薬
US4913907A (en) * 1988-08-15 1990-04-03 Cytopharm, Inc. Porphycene anti-cancer agents and treatment methods
US5010073A (en) * 1989-10-05 1991-04-23 The Rockefeller University Use of liposomes as carriers for metalloporphyrins
DE59102143D1 (de) * 1990-04-03 1994-08-18 Ciba Geigy Ag Parenteral applizierbare Liposomenformulierung aus synthetischen Lipiden.
US5270053A (en) * 1990-04-03 1993-12-14 Ciba-Geigy Corp. Parenterally administerable liposome formulation comprising synthetic lipid
CA2047969A1 (en) * 1990-08-17 1992-02-18 Thomas D. Madden Benzoporphyrin vesicles
GB9111611D0 (en) * 1991-05-30 1991-07-24 Sandoz Ltd Liposomes

Also Published As

Publication number Publication date
JP3020372B2 (ja) 2000-03-15
ATE151984T1 (de) 1997-05-15
MX9300560A (es) 1993-09-01
DE69310014D1 (de) 1997-05-28
US6074666A (en) 2000-06-13
CA2087902A1 (en) 1993-08-06
JPH06122628A (ja) 1994-05-06
GR3023906T3 (en) 1997-09-30
DK0569113T3 (da) 1997-05-20
EP0569113B1 (en) 1997-04-23
EP0569113A1 (en) 1993-11-10
CA2087902C (en) 2006-10-17
DE69310014T2 (de) 1997-11-06
KR970007303B1 (ko) 1997-05-07

Similar Documents

Publication Publication Date Title
ES2100452T3 (es) Composiciones de liposomas de fotosensibilizadores de porfirina.
US5484778C1 (en) Phthalocynine photosensitizers for photodynamic therapy and methods for their use
DE69822496D1 (de) Lipidkomplex-lyophilisat von wasserunlöslichen porphyrinen
TR199500832A2 (tr) Benzimidazol türevleri ve bunlarin medikal terapide kullanimi ve bunlari iceren farmasötik formülasyonlar.
PT758248E (pt) Formulacoes para o factor ix
ATE202286T1 (de) Rhodamin-derivate für die photodynamische therapie von krebs und in-vitro reinigung von leukämien
ATE133418T1 (de) Zusammensetzungen zum erreichen eines lasereffektes und methoden zu deren gebrauch
IT1201149B (it) Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche
FI945838A0 (fi) Ektoiini ja ektoiinijohdannaiset kosteuttavina aineina kosmetiikkatuotteissa
KR880005921A (ko) 의약용 소입자 에어로졸 리포좀 및 의약용 리포좀-약제 조합물
NO992196L (no) Notch
RU95106680A (ru) Бициклические ароматические соединения и содержащие их фармацевтические и косметические композиции
ZA90966B (en) Oxidized diphenylheteroalkanes,the preparation and use thereof
ATE103804T1 (de) Pharmazeutische praeparate.
AU2002344764A1 (en) Dye-sulfenates for dual phototherapy
EP2226318A3 (en) Dye-Azide compounds for dual photherapy
FI902966A0 (fi) Stabil frystorkad polyhematoporfyrineter/esterkomposition.
DE69014666D1 (de) Abgabe von cytotoxischen Mitteln.
ATE74605T1 (de) Tetracyclische chinazolinderivate, herstellung und verwendung.
SE8302751L (sv) 2(1h)-pyridinonderivat, deras framstellning och farmaceutiska beredningar som innehaller dem
ATE5256T1 (de) Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel.
LV10870A (lv) Jauni fosfolipidu atvasinajumi
DE3484355D1 (de) Gefaerbte wasserfreie mittel fuer kosmetische, medizinische und aehnliche zwecke, sowie deren herstellung.
FI890482A0 (fi) B-laktam-antibiotika, foerfarande foer deras framstaellning och deras anvaendning som laekemedel och i laekemedel.
FI972637A0 (fi) K-ryhmän vitamiinin käyttö lisäkilpirauhasen liikatoiminnan hoitoon

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 569113

Country of ref document: ES